Shanghai General Healthy Information And Technology Co.,Ltd. (605186.SH) announced its plan to acquire shares in Brocade Guoxin (Wuhan) Technology Co., Ltd. (the "target company") from four shareholders. The company will purchase 16.75% of the equity from Zhou Xiaoping for 37.6875 million yuan, 13.25% from Zepu Investment for 22.8563 million yuan, 4.00% from Brocade Medical Information for 6.375 million yuan, and another 4.00% from Brocade Guoxin for 6.7914 million yuan.

Prior to this transaction, Shanghai General Healthy Information held a 32% stake in the target company. Upon completion of the acquisition, its ownership will increase to 70%, while Zhou Xiaoping will retain the remaining 30%. As a result, the target company will become a controlled subsidiary of Shanghai General Healthy Information and will be included in its consolidated financial statements.

This move represents a key step in implementing the company's intelligent development strategy and deepening industrial chain collaboration. By increasing its stake and achieving control, Shanghai General Healthy Information aims to fully integrate the technological strengths of both parties in automation hardware, software platforms, and medical artificial intelligence. This integration is expected to enhance the synergy between the company's core products—such as automated pharmacy systems and intravenous drug preparation centers—and the target company's AI application solutions, including B-Klinik intelligent agents, smart operation management platforms, and data governance solutions. The combination will help build more competitive holistic smart hospital solutions and regional healthcare systems.

Additionally, the transaction is anticipated to accelerate the company's expansion into emerging markets, such as county-level medical consortia and healthcare institution data governance. It will further promote the development of integrated "hardware-software-AI" smart medical services. Through business integration and resource sharing, the acquisition is set to improve the company's technological innovation capabilities and market responsiveness, laying a solid foundation for future performance growth.